Warfarin Sodium Stability in Oral Formulations
Warfarin sodium is a low-dose pharmaceutical blood thinner that exists in two forms: the clathrate form and the amorphous form. In commercially available warfarin sodium oral suspension, the active pharmaceutical ingredient (API) is added in the amorphous state. This study investigates the apparent...
Guardado en:
Autores principales: | Evangelia Dimitrokalli, Stefani Fertaki, Michail Lykouras, Petros Kokkinos, Malvina Orkoula, Christos Kontoyannis |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b9548879404946e290e272bf017a5432 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
DEMOGRAPHICS AND MAJOR INDICATIONS FOR THE WARFARIN USE, THE COMPLIANCE RATE AND THE FACTORS CONTRIBUTING IN NON-ADHERENCE AMONG PATIENTS PRESENTING TO A TERTIARY CARDIAC CENTER OF PAKISTAN
por: Muhammad Talha Bin Nazir, et al.
Publicado: (2020) -
Warfarin drug interaction with vitamin K and other foodstuffs
por: Minighin,Elaine C., et al.
Publicado: (2020) -
Eficacia en el control de la anticoagulación de los diferentes fármacos antagonistas de la vitamina K disponibles en Chile
por: Rodríguez,David, et al.
Publicado: (2020) -
Effects of formulation types on pharmacodynamics of warfarin in patients with cerebral infarction and dysphagia
por: Kim YJ, et al.
Publicado: (2019) -
Development ofafoodfrequency questionnaire to determine vitamin k intake in anticoagulated patients: a pilot study
por: Dias Mendonça,Dayana, et al.
Publicado: (2018)